Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022GlobeNewsWire • 10/20/22
Sight Sciences Announces Publication of Data Showcasing Superior Symptoms Improvements with the TearCare® System Compared to LipiFlow* in Patients with Advanced Dry Eye Disease (DED)GlobeNewsWire • 09/29/22
Sight Sciences to Feature Interactive Panel Discussions of Real-World Use of the OMNI Surgical System as a Standalone (Non-Combination Cataract) Glaucoma Treatment at American Academy of Ophthalmology Annual MeetingGlobeNewsWire • 09/28/22
Sight Sciences OMNI® Surgical System to Be Featured in Multiple Presentations at the 2022 European Society of Cataract and Refractive Surgery Annual MeetingGlobeNewsWire • 09/16/22
Sight Sciences Announces Completion of Enrollment in SAHARA, a Randomized Clinical Trial of the TearCare® System vs Restasis®GlobeNewsWire • 09/13/22
Sight Sciences to Present at the Inaugural Gilmartin Group Emerging Growth Company ShowcaseGlobeNewsWire • 08/25/22
Sight Sciences Introduces the SION™ Surgical Instrument – The First Bladeless Device Used in GoniotomyGlobeNewsWire • 08/23/22
Sight Sciences Announces Long-Term Safety and Effectiveness Data of Standalone Use of the OMNI® Surgical System in Patients with Open Angle GlaucomaGlobeNewsWire • 08/16/22
Sight Sciences, Inc. (SGHT) CEO Paul Badawi on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/12/22
Wall Street Analysts Believe Sight Sciences, Inc. (SGHT) Could Rally 121%: Here's is How to TradeZacks Investment Research • 08/09/22
Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 08/04/22
Bears are Losing Control Over Sight Sciences, Inc. (SGHT), Here's Why It's a 'Buy' NowZacks Investment Research • 08/02/22
Sight Sciences Announces the Appointment of Tamara Fountain, M.D. to its Board of DirectorsGlobeNewsWire • 07/19/22
Wall Street Analysts See a 200% Upside in Sight Sciences, Inc. (SGHT): Can the Stock Really Move This High?Zacks Investment Research • 07/18/22
Sight Sciences, Inc (SGHT) CEO Paul Badawi on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/14/22
Sight Sciences to Present at the Upcoming Bank of America Healthcare ConferenceGlobeNewsWire • 04/29/22
Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual MeetingGlobeNewsWire • 04/20/22
Sight Sciences to Report First Quarter 2022 Financial Results on May 10, 2022GlobeNewsWire • 04/14/22
Sight Sciences, Inc. (SGHT) CEO Paul Badawi on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/25/22
Sight Sciences Announces First Patient Treated in TRIDENT European Trial to Evaluate the OMNI® Surgical System in Pseudophakic Eyes with Open-Angle GlaucomaGlobeNewsWire • 03/24/22
Sight Sciences to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022GlobeNewsWire • 03/03/22